DNA Synthesis Inhibitors Market Gains Momentum with Growing Adoption in Oncology and Virology | DelveInsight

DelveInsight's DNA Synthesis Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

“Junk DNA” Provides Surprising New Treatments for Hard-To-Treat Blood Cancers

Junk DNA” may hold the key to treating tough cancers. Existing drugs exploit weaknesses in cells with gene mutations. Researchers at King’s College London have identified a promising strategy for ...
Hospital News

Better grading for brain tumours

Investigate the advancements in detecting brain tumours through TERT expression, leading to more accurate grading and ...
Barron's

These Companies Gain Through Reverse Stock Splits. Shareholders Often Lose Out.

Many successful companies do stock splits to make their shares more affordable for retail investors. Hundreds of struggling companies are doing reverse stock splits to lift their flagging stocks above ...
EMBO Press

Phosphoproteomics of osimertinib-tolerant persister cells reveals targetable kinase-substrate signatures

Phosphoproteomic profiling of Osimertinib drug-tolerant persister (DTP) cells identified dynamic signaling transitions and ...